HCV Screening to Enable Early Treatment of Hepatitis C: A athematical Model to Analyse Costs and Outcomes in Two Populations (original) (raw)

Cost Effectiveness of Universal Screening for Hepatitis C Virus Infection in the Era of Direct-Acting, Pangenotypic Treatment Regimens

Mark Eckman

Clinical Gastroenterology and Hepatology, 2019

View PDFchevron_right

Economic model of a birth cohort screening program for hepatitis C virus

Lisa McGarry

Hepatology, 2012

View PDFchevron_right

Modelling cost-effectiveness and health gains of a "universal" vs. "prioritized" HCV treatment policy in a real-life cohort

Giuseppe Foti

Hepatology (Baltimore, Md.), 2017

View PDFchevron_right

Economic evaluation of screening programs for hepatitis C virus infection: evidence from literature

Silvia Coretti

Risk Management and Healthcare Policy, 2015

View PDFchevron_right

Economic consequences of the implementation of national screening program for chronic HCV infection

Guenka Petrova

Expert Review of Pharmacoeconomics & Outcomes Research, 2019

View PDFchevron_right

Cost-effectiveness of targeted screening for hepatitis C in The Netherlands

Andy Hoepelman

Epidemiology and Infection, 2011

View PDFchevron_right

Optimizing Implementation of Hepatitis C Birth-Cohort Screening and Treatment Strategies

Zelda Zabinsky

MDM Policy & Practice, 2017

View PDFchevron_right

Cost-effectiveness of Universal and Targeted Hepatitis C Virus Screening in the United States

Susana Williams Keeshin

JAMA Network Open, 2020

View PDFchevron_right

Cost effectiveness of screening for hepatitis C virus in asymptomatic, average-risk adults

mendel singer

The American Journal of Medicine, 2001

View PDFchevron_right

Cost-effectiveness model for hepatitis C screening and treatment: Implications for Egypt and other countries with high prevalence

Ahmed M Hablas

Global public health, 2014

View PDFchevron_right

In an era of highly effective treatment, hepatitis C screening of the United States general population should be considered

Linda Henry

Liver International, 2017

View PDFchevron_right

The testing of people with any risk factor for hepatitis C in community pharmacies is cost‐effective

ryan buchanan

Journal of Viral Hepatitis, 2019

View PDFchevron_right

Value of expanding HCV screening and treatment policies in the United States

Brian Edlin

The American journal of managed care, 2016

View PDFchevron_right

Cost-effectiveness of hepatitis C treatment for patients in early stages of liver disease

Philip Spradling, Scott Holmberg

Hepatology (Baltimore, Md.), 2015

View PDFchevron_right

Health policy model: long-term predictive results associated with the management of hepatitis C virus-induced diseases in Italy

M. Andreoni, Salvatore Salomone

ClinicoEconomics and Outcomes Research, 2014

View PDFchevron_right

Cost-effectiveness of Screening for Chronic Hepatitis C Infection in the United States

Mark Eckman

Clinical Infectious Diseases, 2013

View PDFchevron_right

Screening for hepatitis C in genito-urinary medicine clinics: a cost utility analysis

Kim Dalziel

Journal of Hepatology, 2003

View PDFchevron_right

Eradicating hepatitis C: Are novel screening strategies for people who inject drugs cost-effective?

francesco manca

International Journal of Drug Policy, 2020

View PDFchevron_right

Cost-Effectiveness Analysis of Early Treatment of Chronic HCV with Sofosbuvir/Velpatasvir in Italy

Carlo Drago

Applied Health Economics and Health Policy, 2018

View PDFchevron_right

Cost-effectiveness of hepatitis C virus screening, and subsequent monitoring or treatment among pregnant women in the Netherlands

Peter ter Horst

European Journal of Health Economics, 2020

View PDFchevron_right

Uptake of Hepatitis C Screening, Characteristics of Patients Tested, and Intervention Costs in the BEST-C Study

Joseph Kannry

Hepatology, 2016

View PDFchevron_right

Screening for Hepatitis C in injecting drug users: a cost utility analysis

Kim Dalziel

Journal of Public Health, 2004

View PDFchevron_right

Assessing uncertainty in the burden of Hepatitis C Virus: comparison of estimated disease burden and treatment costs in the UK

Roisin Staunton

Journal of viral hepatitis, 2017

View PDFchevron_right

Estimating the impact of hepatitis C virus therapy on future liver-related morbidity, mortality and costs related to chronic hepatitis C

Miguel Casado

Journal of Hepatology, 2005

View PDFchevron_right

Estimation of average diagnosis and treatment costs of hepatitis C

Azadeh Safaee

Gastroenterology and Hepatology from bed to bench, 2012

View PDFchevron_right

The impact of timing and prioritization on the cost-effectiveness of birth cohort testing and treatment for hepatitis C virus in the United States

Ray Kim

Hepatology, 2013

View PDFchevron_right